Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3440322 | American Journal of Obstetrics and Gynecology | 2007 | 11 Pages |
Abstract
This study provides preliminary evidence that insulin-sensitizing drugs may have beneficial effects on the endometrium, although the exact mechanism beyond improving ovulatory function is still unknown. In addition, we suggest that rosiglitazone may be more beneficial than metformin therapy on raised insulin and androgen levels in an obese PCOS population. Combined therapy did not demonstrate significant benefit above and beyond single-agent therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Richard S. MD, Richard J. MD, Laurence M. PhD, Allen R. MA, Carol L. MD, Nancy I. ScD, William C. MD,